PaigeAlderink

Associate

Dallas + 1.214.969.4805

Collegati

Condividi

Paige Alderink represents and advises public and private companies in a variety of capital markets transactions, general corporate governance matters, and shareholder activism issues.

Paige has represented clients in a variety of industries, including energy, pharmaceuticals, and real estate investment.

Esperienze

  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day is representing Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • Cleveland-Cliffs completes $825 million Senior Unsecured Notes offeringJones Day represented Cleveland-Cliffs Inc. (the "Company"), the largest flat-rolled steel producer and manufacturer of iron ore pellets in North America, in connection with its Rule 144A and Regulation S offering of $825 million aggregate principal amount of 7.000% Senior Unsecured Guaranteed Notes due 2032 (the "Notes").
  • Oncor Electric Delivery Company obtains $500 million revolving credit facilityJones Day represented Oncor Electric Delivery Company LLC, Texas's largest transmission and distribution electric utility, in connection with the establishment of a $500 million revolving credit facility with Wells Fargo Bank, National Association, as administrative agent.
    •

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.